Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of inotuzumab ozogamicin in Japan
jRCT2080221145Phase 2Completed
- Start
- Jul 2010
- Modality
- Cytotoxic ADCs → Antibody-Drug Conjugates (ADCs) → Antibody Conjugates → Antibody-Based Therapeutics, Monoclonal Antibodies → Antibody-Based Therapeutics, Small Molecules
01
Overview
Phase 2 trial of inotuzumab ozogamicin in cancer. Started Jul 2010; status: completed.
02
Drugs
inotuzumab ozogamicin
03
Conditions
cancer
Beyond the preview
Go deeper on jRCT2080221145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221145.